Non-adherence of cyclin-dependent kinases 4 and 6 inhibitors reduces overall and progression-free survival in patients with hormone receptor–positive breast cancerConnie Lau, Meghana V. Trivedi, Susan Abughosh et al.|Breast Cancer Research and Treatment|2025Cited by 3